Only four months after IO Biotech…
Only four months after IO Biotech decided to halve its [...]
Tanabe Pharma America’s small…
Tanabe Pharma America’s small molecule designed to boost melanin production [...]
Pfizer is paying $30 million to…
Pfizer is paying $30 million to use Novavax’s adjuvant technology [...]
Boundless Bio has finally given up…
Boundless Bio has finally given up on its hopes of [...]
The therapy in question, dubbed…
The therapy in question, dubbed C-CAR031, is based on AstraZeneca’s [...]
Immunology biotech Agomab…
Immunology biotech Agomab Therapeutics and eye-focused SpyGlass Pharma have both [...]
Vedanta Biosciences has…
Vedanta Biosciences has “significantly reduced” its headcount to channel its [...]
ImmunityBio has reported ongoing…
ImmunityBio has reported ongoing complete responses of up to 15 [...]
The leaders of Chugai…
The leaders of Chugai Pharmaceutical are tired of their company [...]
iRegene’s NouvNeu001 earns dual…
iRegene’s NouvNeu001 earns dual FTD/RMAT status, a first for iPSC [...]